$SYRE Balance Sheet | Understand Stock

$SYRE

$99.05 +$0.00 (0.0%) After hours

$SYRE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Marketable securities
Development receivables
Prepaid expenses and other current assets
Total current assets
Restricted cash
Property and equipment, net
Operating lease right-of-use assets
Other non-current assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable
Nonrelated Party
Related Party
Total accounts payable
CVR liability
Operating lease liabilities
Deferred revenue
Accrued and other current liabilities
Related party accounts payable and other current liabilities
Related Party
Total related party accounts payable and other current liabilities
Related party accounts payable
Total current liabilities
Non-current CVR liability
Non-current operating lease liabilities
Deferred revenue, net of current portion
Other non-current liabilities
TOTAL LIABILITIES
Series B non-voting convertible preferred stock, $0.0001 par value; 150,000 shares authorized, issued, and outstanding as of December 31, 2023.
Series A Non Voting Convertible Preferred Stock
Series B Non Voting Convertible Preferred Stock
Total series B non-voting convertible preferred stock, $0.0001 par value; 150,000 shares authorized, issued, and outstanding as of December 31, 2023.
STOCKHOLDERS’ EQUITY
Preferred stock
Series A Non Voting Convertible Preferred Stock
Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock
Series B Non Voting Convertible Preferred Stock
Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock
Total preferred stock
Common stock, $0.0001 par value; 400,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 88,064,133 shares and 78,189,811 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
Preferred stock, authorized (in shares)
Series A Non Voting Convertible Preferred Stock
Series B Non Voting Convertible Preferred Stock
Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock
Total preferred stock, authorized (in shares)
Preferred stock, issued (in shares)
Series A Non Voting Convertible Preferred Stock
Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock
Series B Non Voting Convertible Preferred Stock
Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock
Total preferred stock, issued (in shares)
Preferred stock, outstanding (in shares)
Series A Non Voting Convertible Preferred Stock
Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock
Series B Non Voting Convertible Preferred Stock
Preferred Stock, Excluding Series A Non Voting Convertible Preferred Stock
Total preferred stock, outstanding (in shares)

Comments